Previous Page  32 / 64 Next Page
Information
Show Menu
Previous Page 32 / 64 Next Page
Page Background

31

Profiles of Doctorate Dissertations

Research Relevance and Potential Impact

There is a low percentage of slow CYP1A2 enzyme activity among Emiratis which is directly

related to the presence of low frequencies of mutant alleles in CYP1A2 gene. Those who are

homozygote for alleles *1C and *3 are considered to be at the highest risk of drug toxicity and

diseases as these alleles are associated with the slowest phenotype status. There is a high

percentage of slow acetylators among Emiratis which is directly related to the presence of high

frequencies of mutant alleles in NAT2 gene. The genotype frequency of the allele *5 was the

highest in this population. Moreover, the genotype frequency of *5B/*7B, *5B/*6A, *7B/*14B

and *4/ *5B were the highest in this population. Individuals who carried NAT2*6A/*6A,

NAT2*6A/*7B, NAT2*7B/*7B, NAT2*5A/*5B, NAT2*5A/*5A genotypes might be at high risk

of toxicity with some drugs and some diseases compared to others as these genotypes are

associated with the slowest phenotype status. Thus, this has a great impact on drug treatment

since drug can be given on an individual bases rather than collectively.

Relevant Publications

N/P

Career Aspirations

My objectives are to seek a teaching and research position in a research or academic institution

where I can share my experience and knowledge with others excited about pharmacogenetics

and where I can research, identify, and provide new challenges, perspectives, and approaches

in the same field of my study. In addition, my grasp of clinical pharmacy, genetics and

pharmacotherapies will provide me the essential tools to substantially contribute in the future

research projects.

To pursue a challenging career in the field of pharmacy and genetics with continuous learning

and contribution to the organization, and providing challenging work environment which allows

me to grow professionally and academically.

To extend my knowledge and experience, to learn more about genetic polymorphisms and to

test the study more extensively and relating it to daily practice.

Apr 27, 2020
Nov 22, 2022